Bionano Genomics Inc BNGO

US Life Sciences Tools & Services

$1.66 ▼ -1.78% ($-0.03)

Open $1.69

Prev Close $1.69

Day Range $1.63 – $1.70

52W Range $1.00 – $2.23

Market Cap $19.55M

Beta 1.75

EPS (TTM) $-3.76

📋 Company Profile

Industry	Life Sciences Tools & Services
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-08-01
Shares Out.	11,470,000
Website	bionano.com/ ↗
Phone	13026587581
Employees	97
Revenue	$8.2M
Gross Profit	$4.3M
Net Income	-$7.4M
Free Cash Flow	-$20.5M
Total Assets	$47.6M
Total Liabilities	$16.0M
Equity	$31.6M

About Bionano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Bionano Genomics Inc is a publicly traded company under the ticker symbol BNGO on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.